comparemela.com
Home
Live Updates
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q4 2022 Earnings Call Transcript : comparemela.com
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q4 2022 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Arbutus Biopharma Corporation Fourth Quarter and Year-End 2022 Financial Results and Corporate Update Conference Call.
Related Keywords
China ,
Qilu ,
Gansu ,
David Hastings ,
William Collier ,
Dave Hastings ,
Lisa Caperelli ,
Brian Skorney ,
Charles Moore ,
Mike Mc ,
Michael Mcelhaugh ,
Qilu Pharmaceutical Company ,
Arbutus Biopharma Corp ,
Arbutus Biopharma Corporation ,
National Cancer Institute On Unsplash ,
Health Photo ,
Arbutus Biopharma Corporation Fourth Quarter ,
Call Transcript March ,
Corporate Update Conference ,
Arbutu Fourth Quarter ,
Corporate Update ,
Arbutus Executive ,
Bill Collier ,
Chief Executive Officer ,
Chief Financial Officer ,
Mike Sofia ,
Chief Scientific ,
National Cancer Institute ,
Greater China ,
Growth Low Dividend Stocks ,
Growth Financial Stocks ,
Dennis Ding ,
comparemela.com © 2020. All Rights Reserved.